-
What the media does and doesn't tell you
07 December 2022
ANH latest infographic on pharma and natural health perspectives of Alzheimer's, obesity, hypertension and cholesterol
-
ANH News Beat (week 12/2024)
21 March 2024
Our weekly roundup of the latest natural and covid news from across the globe in one place. This week Big Pharma profits from obesity; Intermittent fasting - healthful or not?; Mobile phones & brain cancer; HPV vaccines & autoimmunity; Lab-grown pet food; Covid news; ANH-USA updates plus more...
-
News Alerts: Week 19, 2018
10 May 2018
Diet and menopause; fasting and anti-ageing; obesity and exercise; our microbiome in Big Pharma’s sights
-
ANH News Beat (week 06/2024)
07 February 2024
Our weekly roundup of the latest natural and covid news from across the globe in one place. ANH-USA joins new Advocacy Alliance, Hungary muses lab-meat ban, Alzheimer's drug dropped by Big Pharma company, Covid News and updates from ANH-USA plus more...
-
News Alerts: Week 47, 2017
23 November 2017
Obesity a global issue; Flu vaccine fix; Ex GSK boss to become chief UK science officer; How to increase Big Pharma profits overnight!
-
News Alerts: Week 36, 2018
05 September 2018
Environmental campaigner dies; Big Pharma - African exploitation; Cheese and red meat back on the menu; UK energy drink ban; Malaysian sugar tax; UK 5G testing;
-
News Alerts: Week 09, 2018
28 February 2018
Measles hysteria and media bias, Pharma funded antidepressant science, ‘Trust me I’m a Doctor’ on coconut oil benefits and UK Millenials set to be unhealthiest generation yet
-
News Alerts: Week 41, 2017
11 October 2017
New Andrew Wakefield biopic; Has measles been eliminated?; Bee killing pesticides in honey; Pharma’s curcumin nanoparticles
-
You thought vaccines were just for kids?
13 September 2017
As the childhood vaccine schedule becomes full to bursting, Big Pharma is turning its attention to adults
-
News Alerts: Week 44, 2017
31 October 2017
ASA continues to target natural health industry; Scottish Government takes ‘bold action’ on obesity; Just how independent will EFSA’s rules make it?; Pharma’s focus on natural products continues